The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq ... until its acquisition by Merck Sharpe & Dohme in March of 2024. Ms. Eastland previously served as Chief ...

600 mg of Merck Sharp & Dohme LLC. Lupin is the exclusive first-to-file for this product and may be eligible to receive a 180 ...

Sotatercept is the first activin signaling inhibitor therapy for PAH in Canada, a new class of therapy that works by improving the balance between pro-proliferative and anti-proliferative signaling to ...

Lupin receives US FDA tentative approval for raltegravir tablets, USP: Our Bureau, Mumbai Friday, November 8, 2024, 17:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...

Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...

Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Oct 31 (Reuters) - Merck & Co (MRK.N), opens new tab said ... disrupts business and scuttles hospital deals with international pharmaceutical companies. The company expects Gardasil shipments ...

Under this partnership, Teijin and Hilleman Laboratories will leverage their individual strengths to foster greater synergy ...

and has held senior level positions at Penwest Pharmaceuticals, Eurand International BV, Abbott Laboratories and Merck, Sharp and Dohme. His guidance will reinforce Morphocell’s strategic direction as ...